Why the study?
Does histamine H2-receptor blockade with ranitidine alter the cardiovascular reflex response to lower-body negative pressure in healthy volunteers?
Does histamine H2-receptor blockade with ranitidine alter the cardiovascular reflex response to lower-body negative pressure in healthy volunteers?
Histamine H2-receptor blockade with ranitidine attenuates the reflex vasoconstrictor response to simulated hypovolemia, suggesting a role for H2-receptors in cardiovascular control.
Answers are grounded in this paper and cite their sources.
Attenuates reflex responses to simulated hypovolemia in volunteers; leaves open H2-receptor role in clinical cardiovascular regulation.
The role of histamine H2-receptors in cardiovascular control is unknown. In seven healthy volunteers, we studied how histamine H2-receptor blockade affected the reflex response to hypovolaemia induced by lower-body negative pressure (LBNP). In placebo-treated individuals, LBNP down to -40 mmHg did not change systolic pressure but increased diastolic pressure, heart rate, forearm vascular resistance, plasma noradrenaline concentration and plasma renin activity. After pretreatment with ranitidine, a specific histamine H2-receptor antagonist, the diastolic pressure rise no longer sufficed to maintain a constant systolic pressure during LBNP. Ranitidine pretreatment also attenuated the heart rate response and the rise in plasma renin activity induced by LBNP, but did not significantly change the reflex forearm vasoconstriction or the forearm plasma noradrenaline response. The results suggest that histamine H2-receptor blockade attenuates the reflex vasoconstrictor response to lower-body negative pressure. The mechanism behind this effect remains unknown, but the data do not support the idea that the effect is exerted in the skeletal muscle vascular bed.
No takes yet. Share an insight, caveat, or question.
Sjövall et al. (1990) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: